Cosmos Health Inc. · NASDAQ:COSM
Cosmos Health — Investor Presentation (September 2022)
16 slides from Cosmos Health's investor presentation, Sep 27, 2022
Slide 1: Cosmos Holdings Inc. Company Presentation
COSMOS HOLDINGS INC. (NASDAQ: COSM) SEPTEMBER 2022 COMPANY PRESENTATION COSMOS HEALTH
Slide 2: Disclaimer
This presentation is not an offer to sell securities, nor is ita solicitation of an offer to buy securities in any locality, state, country or other jurisdiction where such distribution, publication, availability or Use would be contrary to law or regulation, or which would require any registration
Slide 3: Our mission is to improve people's lives
Our mission is to improve people’s lives. Cosmos Health was founded * HQ in Chicago, IL, US and offices in Thessaloniki, Greece, Athens, Greece, Harlow, UK February 28, 2022 (Nasdaq: COSM) Employees as of December 31, 2021 FY'21 revenue —
Slide 4: Who we are
Who we are + We are Cosmos Health, an fernational healthcare group. + Headquartered in Chicago, Illinois, USA with subsidiaries in European Union and United Kingdom. + We strive to achieve excellence in healthcare globally. OSMOS HEALTH AN INTERNATIONAL HEALTHCARE What we do + We develop and distrib
Slide 5: Our Strategy
OUR STRATEGY We use our extended network to gain access to new markets and business segments. Our focus is high margin nutraceuticals and R&D efforts to develop IP products av, Diversification allows us to exploit new opportunities and c “es synergies while minimizing risk.
Slide 6: The Team
THE TEAM Greg Siokas Chief Executive Officer Greg Siokas has over 20 years of experience in the pharma industry. He has worked in a variety of sectors. His vision of this multinational model of continuous progress and innovation is the basis of for organizational ‘growth. Greg Siokas has a Bachelor'
Slide 7: Cosmos Group Overview
COSMOS GROUP OVERVIEW RICOSMOS.WEALES $skvPHarm —S + Corporate Office in the Chicago + Office area of 850m2, fully + State of the art GDP warehouse, + Warehouse area of 400m2, Board of Trade Building 141 West equipped & air-conditioned of total surface area of 2,900m2, licensed under GDP with Jackso
Slide 8: Market Analysis
MARKET ANALYSIS Nutraceuticals Global Nutraceuticals Market was valued at $455bn in 2021 and is expected to reach $988bn by 2030. Growing at a CAGR of 9.0% (2021-2030) 4 The growing demand for dietary supplements and functional food is expected to be a key driving factor for the market over the fore
Slide 9: Our Business Model
OUR BUSINESS MODEL Nutraceuticals “Sky Premium Life” and “Mediterranation” high-end brands of premium nutraceuticals = Full portfolio of fast-moving and specialty formula products, +85 SKUs + High quality GMP (Good Manufacturing Practices) production with medicine protocol + Catalyst for accelerated
Slide 10: Development of New Products & Product Lines
DEVELOPMENT OF NEW PRODUCTS & PRODUCT LINES Eleonas Chios Mastic Sage, mint, basil, sideritis extracts in + Chios mastic ‘organic extra virgin olive oil = + Inulin Vitamins E, K2, D3 + Digestive system support » — Olympus Mons Chios Mastic & Glutamine Mint, spearmint, thymus extracts, zinc + Chios m
Slide 11: Sky Premium Life - TV Spots Campaign
KY PREMIUM LIFE -TV SPOTS CAMPAIGN HICOSMOS HEALTH
Slide 12: Our Sale Channels
OUR SALE CHANNELS ©) Pharmacy Holland SBarrett CMe
Slide 13: Key Milestones
KEY MILESTONES Uplisting to Nasdaq Stock Exchange Qt 2022 Launch of nutraceutical brand Mediterranation @) Launch of BY Acquisition of nutraceutical brand Decahedron Ltd in UK Sky Premium Life RE — 4 Q22017 4 2019 =» > 2017 2018 2019 2020 bias - Change of . : name from a Sng Cosmos 5 Hoes hel i , Qu
Slide 14: Key - Recent 2022 Events
KEY - RECENT 2022 EVENTS Date Description Feb 28, 2022 ‘Cosmos Health announced Nasdaq Uplisting and concurrent private placement. Mar 28-Apr 12, 2022 Launch of: * Sky Premium Life Prostatium supplement for prostate health and Brainlit supplement for brain health. + New premium nutritional supplemen
Slide 15: Financial Highlights H1 2022
inancial Highlights H1 2022 Adjusted EBITDA Total revenue Gross profit margin Adj. net income (loss) vvvyv Cash & cash equiv ICOSMOS HEALTH Trading data (09/22/2022) Stock price Market cap. 52 week low / high Avg. daily volume vvvev Shares outstanding ‘Common Shares Outstanding Warrants Preferred St
Slide 16: Thank You
THANK YOU 141 West Jackson Blvd., Suite 4236 Chicago, 1.60604 info@cosmoshold.com [S| (8 be (US) +1 312 536 3102
Cosmos Holdings — Investor Presentation (September 2022) on 6ix